Your browser doesn't support javascript.
loading
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial.
Chaft, Jamie E; Oezkan, Filiz; Kris, Mark G; Bunn, Paul A; Wistuba, Ignacio I; Kwiatkowski, David J; Owen, Dwight H; Tang, Yan; Johnson, Bruce E; Lee, Jay M; Lozanski, Gerard; Pietrzak, Maciej; Seweryn, Michal; Byun, Woo Yul; Schulze, Katja; Nicholas, Alan; Johnson, Ann; Grindheim, Jessica; Hilz, Stephanie; Shames, David S; Rivard, Chris; Toloza, Eric; Haura, Eric B; McNamee, Ciaran J; Patterson, G Alexander; Waqar, Saiama N; Rusch, Valerie W; Carbone, David P.
Afiliação
  • Chaft JE; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Oezkan F; Weill Cornell Medical College, New York, NY, USA.
  • Kris MG; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Bunn PA; University Medicine Essen, Ruhrlandklinik, Department of Interventional Pulmonology, University Duisburg-Essen, Essen, Germany.
  • Wistuba II; German Cancer Research Center (DKFZ), A420, Heidelberg, Germany.
  • Kwiatkowski DJ; Fifth Medical Department, Section of Pulmonology, Faculty of the University of Heidelberg, University Medicine Mannheim, Mannheim, Germany.
  • Owen DH; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Tang Y; Weill Cornell Medical College, New York, NY, USA.
  • Johnson BE; University of Colorado School of Medicine, Aurora, CO, USA.
  • Lee JM; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lozanski G; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Pietrzak M; Brigham and Women's Hospital, Boston, MA, USA.
  • Seweryn M; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Byun WY; The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Schulze K; Brigham and Women's Hospital, Boston, MA, USA.
  • Nicholas A; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Johnson A; Brigham and Women's Hospital, Boston, MA, USA.
  • Grindheim J; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Hilz S; The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Shames DS; The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Rivard C; The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Toloza E; Biobank Lab, Department of Molecular Biophysics, University of Lodz, Lodz, Poland.
  • Haura EB; Centre for Data Analysis, Modeling and Computational Sciences, University of Lodz, Lodz, Poland.
  • McNamee CJ; The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Patterson GA; Genentech, Inc., South San Francisco, CA, USA.
  • Waqar SN; Genentech, Inc., South San Francisco, CA, USA.
  • Rusch VW; Genentech, Inc., South San Francisco, CA, USA.
  • Carbone DP; Genentech, Inc., South San Francisco, CA, USA.
Nat Med ; 28(10): 2155-2161, 2022 10.
Article em En | MEDLINE | ID: mdl-36097216
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Terapia Neoadjuvante / Anticorpos Monoclonais Humanizados / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Terapia Neoadjuvante / Anticorpos Monoclonais Humanizados / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article